Scleroderma mystery: could a simple hormone be involved?
NCT ID NCT04746313
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether people with systemic sclerosis (scleroderma) have higher levels of the hormone prolactin in their blood. Researchers measured prolactin in 71 patients and compared them to healthy volunteers. The goal was to understand if prolactin plays a role in the disease, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERPROLACTINEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hop Claude Huriez Chu Lille
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a skin patch ease stomach pain in scleroderma?
- Blood thinner may stop autoimmune disease before it starts
- Can online therapy help scleroderma patients manage daily life?
- Pandemic stress hits hard for arthritis patients
- New shot aims to tame rare autoimmune disease
- Could weak legs be making it hard to breathe? new study investigates